Pharmena S.A. (WSE:PHR)
Poland · Delayed Price · Currency is PLN 3.200
+0.020 (0.63%)
Aug 14, 2026, 12:35 PM CET
Pharmena Market Cap
Pharmena has a market cap or net worth of 35.64 million as of August 14, 2026. Its market cap has decreased by -11.11% in one year.
Market Cap
35.64M
Enterprise Value
35.57M
Revenue
1.61M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.20
ChartMarket Cap Chart
Since August 25, 2008, Pharmena's market cap has decreased from 171.99M to 35.64M, a decrease of -79.28%. That is a compound annual growth rate of -8.38%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 35.64M | 23.08% |
| Dec 30, 2025 | 28.96M | -32.11% |
| Dec 30, 2024 | 42.66M | -46.06% |
| Dec 29, 2023 | 79.08M | 26.79% |
| Dec 30, 2022 | 62.37M | -29.20% |
| Dec 30, 2021 | 88.10M | -10.89% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Syn2bio | 580.49M |
| Captor Therapeutics Spolka Akcyjna | 461.89M |
| Bioceltix | 452.54M |
| Ryvu Therapeutics | 404.60M |
| BIOTON | 334.87M |
| Synthaverse | 223.90M |
| Poltreg | 159.15M |
| Molecure | 127.53M |